Publications & Works

Publication Network
Articles 22
All (22)
SCI-E, SSCI, AHCI (18)
SCI-E, SSCI, AHCI, ESCI (18)
Scopus (18)
Other Publications (4)

1. Evaluation of non-invasive diagnostic methods as indicators of fibrosis in patients with nonalcoholic fatty liver disease

Atay K., Canbakan B., Alan O., Koroglu E., Hatemi I., Kepil N., et al.
BIOMEDICAL RESEARCH-INDIA , vol.28, no.2, pp.565-570, 2017 (SCI-Expanded) identifier identifier

2. The Role of EUS and EUS-FNA in the Management of Pancreatic Masses: Five-Year Experience

Caglar E., Senturk H., Atasoy D., Sisman G., Cannakan B., Tuncer M.
HEPATO-GASTROENTEROLOGY , vol.60, no.124, pp.896-899, 2013 (SCI-Expanded) identifier identifier identifier

3. Reliability of caspase activity as a biomarker of hepatic apoptosis in nonalcoholic fatty liver disease

Canbakan B., Senturk H., Canbakan M., TOPTAŞ T., Tuncer M.
BIOMARKERS IN MEDICINE , vol.5, no.6, pp.813-815, 2011 (SCI-Expanded) identifier identifier identifier

4. Adult Langerhans cell histiocytosis and sclerosing cholangitis: a case report and review of the literature

Hatemi I., Baysal B., Senturk H., Behzatoglu K., Bozkurt E. R., Ozbay G.
HEPATOLOGY INTERNATIONAL , vol.4, no.3, pp.653-658, 2010 (SCI-Expanded) identifier identifier identifier

5. Pancreas Cytology Evaluation Of 306 Cases (8 Years Of Experience)

Ramazanoglu S. R., Uygun N., Cakalir C., Durak H., Goksel S., Dogusoy G., et al.
CANCER CYTOPATHOLOGY , vol.114, no.5, pp.449, 2008 (SCI-Expanded) identifier

6. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk

Tahan V., Canbakan B., Balci H., DANE F., Akin H., Can G., et al.
HEPATO-GASTROENTEROLOGY , vol.55, no.85, pp.1433-1438, 2008 (SCI-Expanded) identifier identifier identifier

7. Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease

Canbakan B., Senturk H., TAHAN V., HATEMİ I., Balci H., Toptas T., et al.
ACTA GASTRO-ENTEROLOGICA BELGICA , vol.70, no.3, pp.277-284, 2007 (SCI-Expanded) identifier identifier identifier

8. Liver steatosis in hepatitis C positive hemodialysis patients and factors affecting IFN-2a treatment

Yildirim B., Durak H., Ozaras R., Canbakan B., Ozkan P., Ozbay G., et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , vol.41, no.10, pp.1235-1241, 2006 (SCI-Expanded) Sustainable Development identifier identifier identifier

9. Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response

ter Borg M. J., van Zonneveld M., Zeuzem S., Senturk H., Akarca U. S., Simon C., et al.
HEPATOLOGY , vol.44, no.3, pp.721-727, 2006 (SCI-Expanded) Sustainable Development identifier identifier identifier

10. Vater's papillary stenosis in a child with abdominal pain

YILMAZ E., Erkan T., Senturk H., KUTLU T., CULLU F. C.
PEDIATRICS INTERNATIONAL , vol.48, no.4, pp.406-408, 2006 (SCI-Expanded) identifier identifier identifier

11. Hepatitis C virus risk factors in the Turkish community

Yildirim B., Tahan V., Ozaras R., Aytekin H., Mert A., Tabak F., et al.
DIGESTIVE DISEASES AND SCIENCES , vol.50, no.12, pp.2352-2355, 2005 (SCI-Expanded) Sustainable Development identifier identifier identifier

12. Sexual transmission of HCV between spouses

Tahan V., Karaca C., Yildirim B., Bozbaş A., Ozaras R., Demir K., et al.
American Journal of Gastroenterology , vol.100, no.4, pp.821-824, 2005 (SCI-Expanded) Sustainable Development identifier identifier identifier

13. Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats

TAHAN V., Ozaras R., Canbakan B., Uzun H., Aydin S., YILDIRIM B., et al.
JOURNAL OF PINEAL RESEARCH , vol.37, no.2, pp.78-84, 2004 (SCI-Expanded) identifier identifier identifier

14. The prevalence of hepatic granulomas in chronic hepatitis C

Ozaras R., tahan v., Mert A., Uraz S., Kanat M., Tabak F., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.38, no.5, pp.449-452, 2004 (SCI-Expanded) Sustainable Development identifier identifier identifier

15. Spontaneous hematoma of the rectus abdominis muscle: a rare cause of acute abdominal pain in the elderly

Ozaras R., Yilmaz M. H., Tahan V., Uraz S., Yiğitbaşı R., Senturk H.
ACTA CHIRURGICA BELGICA , vol.103, no.3, pp.332-333, 2003 (SCI-Expanded) identifier identifier identifier

16. N-acetylcysteine attenuates alcohol-induced oxidative stress in the rat

ÖZARAS R., TAHAN V., AYDIN S., UZUN H., KAYA S., ŞENTÜRK H.
WORLD JOURNAL OF GASTROENTEROLOGY , vol.9, no.1, pp.125-128, 2003 (SCI-Expanded) identifier identifier identifier identifier

17. Losartan-induced hepatic injury

Tabak F., Mert A., Ozaras R., Bıyıklı M., Ozturk R., Ozbay G., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.34, no.5, pp.585-586, 2002 (SCI-Expanded) identifier identifier identifier

18. Respirology

MERT A., BİLİR M., TABAK Ö. F., ÖZARAS R., ÖZTÜRK R., ŞENTÜRK H., et al.
Miliary tuberculosis: clinical manifestations, diagnosis and outcome in 38 adults , vol.6, pp.217-224, 2001 (Peer-Reviewed Journal)

19. Spontaneous pneumothorax: a rare complication of miliary tuberculosis

MERT A., Akman C., ÖZARAS R., TABAK Ö. F., ÖZTÜRK R., ŞENTÜRK H., et al.
Ann Thorac Cardiovasc Surg , vol.7, pp.45-48, 2001 (Peer-Reviewed Journal) Sustainable Development

20. Role of TTV in acute non-A-E hepatitis in Turkey

Tabak F., Mert A., Ozturk R., Ergin S., Senturk H., Aktuglu Y.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , vol.32, no.4, pp.447-448, 2000 (SCI-Expanded) Sustainable Development identifier identifier identifier

21. HBsAg ve anti-HBs negatif, anti-HBc pozitif olguların çeşitli yönlerden incelenmesi

MERT A., ŞENTÜRK H., Süve İ., TABAK Ö. F., Akdoğan M., Kurtoğlu E., et al.
Viral Hepatit Derg , vol.2, pp.92-95, 1996 (Peer-Reviewed Journal)

22. Sürekli AST ve ALT yüksekliği olan hastalarda etyoloji

MERT A., TABAK Ö. F., ÖZTÜRK R., Gözükara Y., ÖZBAY G., ŞENTÜRK H.
Cerahpaşa Tıp Fak Derg , vol.25, pp.481-485, 1994 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences 50

1. HBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE

Sonneveld M. J., Rijckborst V., Senturk H., Zeuzem S., AKARCA U. S., Simon K., et al.
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 29 October - 02 November 2010, vol.52, (Summary Text) Sustainable Development identifier

2. The Correlation of Hepatic Apoptotic Markers and Histology and Their Predictive Role in Estimating the Response to Therapy in Chronic Hepatitis C

ÖZARAS R., TABAK Ö. F., Tahan V., ÖZBAY G., Çelikel Ç. A., MİDİLLİ K., et al.
The 19th Conference of the Asian Pacific Association for the Study of the Liver, Hongkong, Hong Kong, 13 - 16 February 2009, vol.3, pp.187, (Full Text) Sustainable Development

3. HEPATIC APOPTOTIC MARKERS ARE ASSOCIATED WITH HISTOLOGY BUT MAY NOT PREDICT THE RESPONSE TO THERAPY IN CHRONIC HEPATITIS C

Ozaras R., Tahan V., Ozbay G., ÇELİKEL Ç., Midilli K., Kaygusuz A., et al.
59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica, 31 October - 04 November 2008, vol.48, (Summary Text) Sustainable Development identifier

4. Correlation of quantitative assay of HBsAg and HBV-DNA levels during chronic HBV treatment.

ÖZARAS R., TABAK Ö. F., Kaygusuz A., Tahan V., ÖZTÜRK R., MERT A., et al.
17th APASL Conference, Kyoto, Japan, 27 - 30 March 2007, vol.1, no.7, pp.7, (Full Text)

5. The reliability of fibrotest in hepatitis C patients on renal replacement therapy

ŞENTÜRK H., Canbakan B., Yildirim B., ÖZARAS R., Hatemi İ., ÖZBAY G., et al.
17th APASL Conference, Kyoto, Japan, 27 - 30 March 2007, vol.1, no.33, pp.33, (Full Text) Sustainable Development

6. Apoptotic cell death during HBV treatment: does it correlate with biochemisty or viral kinetics?

ÖZARAS R., TABAK Ö. F., Tahan V., ÖZTÜRK R., MERT A., ŞENTÜRK H.
17th APASL Conference, Kyoto, Japan, 27 - 30 March 2007, vol.1, no.5, pp.5, (Full Text)

7. Pegylated interferon and ribavirin combination in hepatitis B and C coinfection: a pilot study.

ŞENTÜRK H., ÖZARAS R., Hatemi İ., Canbakan B., TABAK Ö. F., ÖZBAY G., et al.
17th APASL Conference, Kyoto, Japan, 27 - 30 March 2007, vol.1, pp.152, (Full Text) Sustainable Development

8. The efficacy of pre-S containing HBV vaccine with lamivudine in treatment of chronic HBV infection.

ŞENTÜRK H., TABAK Ö. F., Erdem L., ÖZARAS R., Canbakan B., MERT A., et al.
17th APASL Conference, Kyoto, Japan, 27 - 30 March 2007, vol.1, no.19, pp.19, (Full Text) Sustainable Development

9. Is HCV genotyping cost-effective in Turkey?

Tahan V., ÖZARAS R., Uraz S., KARACA Ç., Eren F., Danalioglu A., et al.
17th APASL Conference, Kyoto, Japan, 27 - 30 March 2007, vol.1, pp.139, (Full Text)

10. HBV Tedavisi Sırasında Apoptotik Hücre Ölümünün Biyokimyasal Ve Viral Kinetiklerle İlişkisi.

ÖZARAS R., TABAK Ö. F., Kaygusuz A., Tahan V., ÖZTÜRK R., MERT A., et al.
23. Ulusal Gastroenteroloji Kongresi, İstanbul, Turkey, 4 - 07 November 2006, vol.1, pp.1, (Full Text)

11. The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.

Canbakan B., ŞENTÜRK H., TABAK Ö. F., Akdoğan M., ÖZARAS R., Tahan V., et al.
Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Chicago, United States Of America, 14 - 19 May 2005, vol.128, no.4, pp.771-772 Sustainable Development

12. Prevalence and significance of hepatic granulomas in chronic hepatitis B

Tahan V., ÖZARAS R., Lacevic N., Özden E., Özdoğan O. C., MERT A., et al.
Asia Pacific Association for the Study of the Liver, 14th Biennal Conference,, Yeni Delhi, India, 11 - 15 December 2004, vol.19, pp.741, (Full Text) Sustainable Development

13. Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats.

Tahan V., ÖZARAS R., Canbakan B., UZUN H., AYDIN S., Yildirim B., et al.
21. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 31 August - 05 September 2004, vol.1, pp.1, (Full Text)

14. Dendritic cell count in patients with chronic hepatitis C and their change with treatment.

Yildirim B., Aygün C., Tahan V., ÖZARAS R., Besler M., Demir G., et al.
XII Falk Liver Week, Freiburg, Germany, 17 - 19 October 2003, vol.1, pp.89, (Full Text) Sustainable Development

15. The prevalence of hepatic granulomas in chronic hepatitis C.

ÖZARAS R., Tahan V., MERT A., TABAK Ö. F., Avşar E., ÖZBAY G., et al.
13th European Congress of Clinical Microbiology and Infectious Diseases., Glasgow, United Kingdom, 10 - 13 May 2003, vol.9, pp.1178, (Full Text) Sustainable Development

16. HCV Enfeksiyonunda Aile İçi Geçiş

Yildirim B., TABAK Ö. F., ÖZARAS R., Aytekin H., ŞENTÜRK H., MERT A.
6. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 31 October - 02 November 2002, vol.1, pp.34

17. Hepatit C Virüsünde Olası Bulaşma Kaynakları

Yildirim B., TABAK Ö. F., ÖZARAS R., Aytekin H., Barut G., MERT A., et al.
6. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 31 October - 02 November 2002, vol.1, pp.35 Sustainable Development

18. Screening for Iron Overload in Turkish Populatıon,

Barut G., Balcı H., Bozdayı M., Hatemi I., ÖZÇELİK D., Sentürk H.
12th World Congress of THA Internatıonal Assocıatıon of Surgeons and Gastroenterologısts,, İstanbul, Turkey, 3 - 06 September 2002, pp.9-11, (Summary Text)

19. N-Acetyl Cysteine Mitigate the Toxic Effects of Ethanol on the Oxidant – Antioxidant System of Rat Plasma and Brain

AYDIN S., ÖZARAS R., UZUN H., BELCE A., Altuğ T., Tahan V., et al.
2nd International Meeting on Free Radicals in Health and Disease. The Role of Oxidants and Antioxidants in the Regulation of Chronic Diseases and Free Radical School on Measurement of Free Radicals, Evaluation of Oxidant/Antioxidant Status and Clinical Applications, İstanbul, Turkey, 1 - 04 May 2002, pp.106, (Full Text)

20. Ornidazole-induced liver damage.

TABAK Ö. F., ÖZARAS R., Erzin Y. Z., Çelik A. D., MERT A., ÖZTÜRK R., et al.
12th European Congress of Clinical Microbiology and Infectious Diseases., Milano, Italy, 21 - 24 April 2002, vol.8, pp.1356, (Full Text)

21. Antiphospholipid syndrome as a cause of fever of unknown origin.

ÖZARAS R., METE B., ÖZTÜRK R., MERT A., TABAK Ö. F., ŞENTÜRK H., et al.
12th European Congress of Clinical Microbiology and Infectious Diseases., Milano, Italy, 21 - 24 April 2002, vol.8, pp.1580

22. The effect of melatonin on dimethylnitrosamine-induced liver fibrosis in rats.

Tahan V., ÖZARAS R., UZUN H., AYDIN S., DONDURMACI S., ÖZBAY G., et al.
52nd Annual Meeting, The American Association For The Study Of Liver Diseases (AASLD), Texas, United States Of America, 9 - 13 November 2001, vol.34, no.4, pp.394, (Full Text)

23. Kronik hepatit C infeksiyonu olan hastalarda oral liken planus prevalansı.

Engin B., Oğuz O., MERT A., ÖZARAS R., Uraz S., Tahan V., et al.
IV. Ulusal Hepatoloji Kongresi ve Uluslararası Falk Workshop, İstanbul, Turkey, 14 - 16 June 2001, vol.1, pp.129, (Full Text) Sustainable Development

24. Kronik hepatit polikliniği: 9 yıllık Cerrahpaşa deneyimi

TABAK Ö. F., ŞENTÜRK H., MERT A., Tahan V., ÖZARAS R., Uraz S., et al.
IV. Ulusal Hepatoloji Kongresi ve Uluslararası Falk Workshop, İstanbul, Turkey, 14 - 16 June 2001, vol.1, pp.158, (Full Text) Sustainable Development

25. Hemodiyaliz Hastalarında HCV Enfeksiyonunun Histopatolojik Değerlendirmesi

Yildirim B., MERT A., Özkan P., TABAK Ö. F., ÖZARAS R., ŞENTÜRK H.
IV. Ulusal Hepatoloji Kongresi ve Uluslararası Falk Workshop, İstanbul, Turkey, 13 - 16 June 2001, vol.1, pp.176, (Full Text)

26. The effect of interferon-? induction treatment with or without ribavirin in chronic hepatitis C: interim analysis.

ŞENTÜRK H., Ersöz G., ÖZARAS R., Kaymakoğlu S., Bozkaya H., MERT A., et al.
Digestive Disease Week, Atlanta, United States Of America, 20 - 23 May 2001, vol.1, pp.2884, (Full Text) Sustainable Development

27. N-acetyl cysteine attenuates alcohol-induced oxidative stress in the rat

ÖZARAS R., Tahan V., UZUN H., AYDIN S., DONDURMACI S., ŞENTÜRK H.
American Gastroenterology Week, Atlanta, United States Of America, 19 - 23 May 2001, pp.1, (Full Text)

28. . Sarcoidosis developed after use of interferon for chronic hepatitis C

Tahan V., ÖZARAS R., MERT A., TABAK Ö. F., Çağatay T., ŞENTÜRK H.
11th European Congress of Clinical Microbiology and Infectious Diseases., İstanbul, Turkey, 1 - 04 April 2001, vol.7, pp.144, (Full Text) Sustainable Development

29. The results of hepatitis B vaccination in sarcoidosis.

MERT A., BİLİR M., ÖZARAS R., TABAK Ö. F., Karayel T., ŞENTÜRK H.
10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.150, (Full Text) Sustainable Development

30. Prevalence of Serum Antibodies to Hepatitis C Virus is not increased in patients with sarcoidosis.

MERT A., BİLİR M., ÖZARAS R., TABAK Ö. F., Sipahi S., ÖZTÜRK R., et al.
10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.151 Sustainable Development

31. Evaluation of HBsAg positive blood donors and results of long-term follow-up.

MERT A., TABAK Ö. F., ÖZARAS R., BİLİR M., ÖZTÜRK R., ŞENTÜRK H., et al.
10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.18, (Full Text)

32. Prevalence of serum antibodies to hepatitis C virus in patients with multiple sclerosis.

MERT A., Altıntaş A., BİLİR M., ÖZARAS R., TABAK Ö. F., ÖZTÜRK R., et al.
10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.151, (Full Text) Sustainable Development

33. Significance of infectious diseases in etiology of hepatic granulomas: Evaluation of 74 cases.

MERT A., BİLİR M., ÖZARAS R., Çetinkaya A., Tahan V., Yirmibeşcik S., et al.
10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, Sweden, 28 - 31 May 2000, vol.6, pp.151 Sustainable Development

34. Asemptomatik HBsAg Taşıyıcılarının Doğal Seyri

MERT A., TABAK Ö. F., ŞENTÜRK H., BİLİR M., ÖZARAS R., ÖZTÜRK R., et al.
III. Ulusal Hepatoloji Kongresi, İstanbul, Turkey, 27 - 29 May 1999, vol.1, pp.51, (Full Text)

35. The meaning of isolated anti-HBc positivity.

MERT A., ŞENTÜRK H., TABAK Ö. F., ÖZARAS R., Akdoğan M., Sander E., et al.
10th International Symposium on Viral Hepatitis and Liver Disease, Atlanta, United States Of America, 9 - 13 April 1999, vol.1, pp.21, (Full Text)

36. Kronik Hepatit B’li Hastaların Çocuklarında Hepatit B Virüs Göstergeleri

Tahan V., MERT A., ÖZARAS R., TABAK Ö. F., Akdoğan M., ŞENTÜRK H.
IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.28 Sustainable Development

37. Kronik Hepatit C’li Hastaların Çocuklarında Anti-HCV Pozitifliği

Tahan V., TABAK Ö. F., ÖZARAS R., MERT A., Akdoğan M., ŞENTÜRK H.
IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.66, (Full Text) Sustainable Development

38. Kronik Sağlıklı HBsAg Taşıyıcılarının Çeşitli Yönlerden Değerlendirilmesi

ÖZARAS R., MERT A., ŞENTÜRK H., TABAK Ö. F., Tahan V., Başaranoğlu M., et al.
IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.37, (Full Text)

39. Kronik Hepatit C Havuzuna Hangi Yollarla Hasta Akmaktadır?

Tahan V., TABAK Ö. F., ÖZARAS R., MERT A., Akdoğan M., ŞENTÜRK H.
IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.71, (Full Text) Sustainable Development

40. Anti-HCV ve HCV-RNA Pozitif, ALT Normal Olgularda Karaciğer Histolojisi

ÖZARAS R., MERT A., Tahan V., TABAK Ö. F., Akdoğan M., ŞENTÜRK H.
IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.65, (Full Text)

41. Sağlıklı HBsAg Taşıyıcılarında HBV-DNA Pozitiflik Oranı

ÖZARAS R., MERT A., ŞENTÜRK H., TABAK Ö. F., Tahan V., Akdoğan M., et al.
IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.30

42. Tedavisinde İnterferon Uygulanmasının Uzun Dönem Sonuçları

ÖZARAS R., TABAK Ö. F., MERT A., Tahan V., Akdoğan M., ŞENTÜRK H.
IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.72

43. Sağlıklı Kişilerde HBsAg(-), Anti-HBs(-) ve Anti-HBc(+)’liği ne Anlama Gelmektedir?

MERT A., TABAK Ö. F., ŞENTÜRK H., ÖZARAS R., Başaranoğlu M., AKTUĞLU Y.
IV. Ulusal Viral Hepatit Simpozyumu, Ankara, Turkey, 4 - 06 November 1998, vol.1, pp.36

44. Coinfection with hepatitis B and C in patients with chronic hepatitis: effects of interferon treatment

TABAK Ö. F., Tahan V., ÖZARAS R., MERT A., Yildirim B., Akdoğan M., et al.
European Association for the Study of the Liver, Postgraduate Course., İstanbul, Turkey, 26 - 27 June 1998, vol.1, pp.27, (Full Text) Sustainable Development

45. The effect of diabetes mellitus on the treatment of chronic hepatitis C with interferon.

TABAK Ö. F., ÖZARAS R., Tahan V., MERT A., Akdoğan M., ŞENTÜRK H.
European Association for the Study of the Liver, Postgraduate Course., İstanbul, Turkey, 26 - 27 June 1998, vol.1, pp.28, (Full Text) Sustainable Development

46. HCV-RNA positive blood donors: a histologic study.

MERT A., Yildirim B., Otağ F., BİLİR M., TABAK Ö. F., Akdoğan M., et al.
European Association for the Study of the Liver, Postgraduate Course., İstanbul, Turkey, 26 - 27 June 1998, vol.1, pp.26

47. Transmission of hepatitis C between spouses.

MERT A., TABAK Ö. F., ÖZARAS R., Yildirim B., Tahan V., Seyhan E., et al.
Recent Advances in the Diagnosis of Sexually Transmitted Diseases., İstanbul, Turkey, 10 - 13 June 1998, vol.1, pp.52, (Full Text) Sustainable Development

48. Infectivity of chronic asymptomatic HBsAg carriers for their spouses.

MERT A., TABAK Ö. F., Tahan V., Yildirim B., ÖZARAS R., Otağ F., et al.
Recent Advances in the Diagnosis of Sexually Transmitted Diseases., İstanbul, Turkey, 10 - 13 June 1998, vol.1, pp.50, (Full Text)

49. Should individuals with isolated anti-HBc be immunized against hepatits B virus

MERT A., BAŞARAN G., ÖZTÜRK R., TABAK Ö. F., ŞENTÜRK H., AKTUĞLU Y.
First World Congress on vaccines and immunization, İstanbul, Turkey, 26 - 30 April 1998, pp.0-17, (Full Text)

50. Rastlantısal ALT yüksekliği saptanan olgularda etyoloji

İlhan M., ŞENTÜRK H., MERT A., ÖZTÜRK R.
1.Ulusal Hepatoloji Kongresi, İstanbul, Turkey, 1 - 03 June 1995, pp.77, (Summary Text)
Metrics

Publication

72

Publication (WoS)

20

Publication (Scopus)

18

Citation (WoS)

456

H-Index (WoS)

10

Citation (Scopus)

521

H-Index (Scopus)

10
UN Sustainable Development Goals